Key result
Invasive coronary physiology indices may play an adjuvant role in guiding treatment and providing further risk stratification in patients suffering from acute coronary syndromes.
Why the study?
Do invasive coronary physiology indices guide treatment and provide risk stratification in patients with acute coronary syndromes?
Do invasive coronary physiology indices guide treatment and provide risk stratification in patients with acute coronary syndromes?
This review highlights the potential adjuvant role of invasive coronary physiology indices for risk stratification and treatment guidance in complex ACS scenarios.
May refine ACS risk stratification; hypothesis-generating and requires randomized trials before practice change.
Acute coronary syndromes (ACS) are prevalent, portend a poor prognosis and represent the most threatening manifestation of coronary artery disease. While very little doubt exists about the clinical benefit of restoring culprit vessels' patency in patients admitted for ACS, the risk stratification and individual treatment strategy in these complex scenarios is not always straight forward. This is because the extension of myocardial damage and left ventricle recovery are difficult to predict, and a sizable proportion of patients admitted for ACS have bystander multivessel disease. This review summarizes available literature on the adjuvant role of invasive coronary physiology indices in guiding treatment and providing further risk stratification in patients suffering from ACS.
No takes yet. Share an insight, caveat, or question.
Echavarría‐Pinto et al. (2015) conducted a review in Acute coronary syndromes. Invasive coronary physiology indices was evaluated. Invasive coronary physiology indices may play an adjuvant role in guiding treatment and providing further risk stratification in patients suffering from acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: